Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

Although the stock market was having a generally strong week, that isn't the case for vaccine technology company Moderna ...

BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

Moderna MRNA provided an update on its financial outlook and pipeline progress at the J.P. Morgan Healthcare Conference. At ...

The internet and social media, along with the COVID-19 pandemic ... If the vaccine is successful after human trials, it then goes before the scientists at the Food and Drug Administration ...

The article " Pfizer: 4 Reasons to Buy This Stock " first appeared on MarketBeat.

Federal public health agencies are known for black-and-white public service announcements that portray their favorite COVID-19 treatments as universally ... particularly the effectiveness of each new ...

RFK Jr., who's nominated to become the next health secretary, asked the federal government to revoke its authorization of all ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

The agency published the information online on Friday, along with the National Advisory Committee on Immunization’s COVID-19 vaccine guidance for 2025 through to the summer of 2026.

A Food and Drug Administration (FDA ... especially due to COVID-19. The draft guidance is not legally binding and applies only to pulse oximeters used in hospitals and other medical settings.